Malleable multi-component implants and materials therefor
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/00
A61F-002/02
A61K-038/16
A61P-019/00
A61L-027/26
A61L-027/54
출원번호
US-0056549
(2008-03-27)
등록번호
US-8840913
(2014-09-23)
발명자
/ 주소
McKay, William F.
Scifert, Jeffrey L.
Remsen, Kathy L.
Billy, Didier
Gillissen, Mirian
Vickers, Scott M.
출원인 / 주소
Warsaw Orthopedic, Inc.
대리인 / 주소
Sorell Lenna & Schmidt LLP
인용정보
피인용 횟수 :
1인용 특허 :
56
초록▼
Described are implantable, malleable medical materials comprising mineral particles, insoluble collagen fibers, and a gel-forming polysaccharide component and/or another added gel-former. The malleable medical materials can be used treat bone or other tissue defects in patients, including in conjunc
Described are implantable, malleable medical materials comprising mineral particles, insoluble collagen fibers, and a gel-forming polysaccharide component and/or another added gel-former. The malleable medical materials can be used treat bone or other tissue defects in patients, including in conjunction with biologically active factors such as osteogenic proteins. Also described are methods and materials that can be used to prepare the malleable medical materials.
대표청구항▼
1. An implantable medical material, comprising: a malleable, cohesive, shape-retaining putty comprising about 40% to about 75% by weight of water;polyethylene glycol;said putty including mineral particles dispersed therein at a level of about 0.25 g/cc to about 0.55 g/cc, the mineral particles compr
1. An implantable medical material, comprising: a malleable, cohesive, shape-retaining putty comprising about 40% to about 75% by weight of water;polyethylene glycol;said putty including mineral particles dispersed therein at a level of about 0.25 g/cc to about 0.55 g/cc, the mineral particles comprising biphasic calcium phosphate having a weight ratio of tricalcium phosphate:hydroxyapatite of about 70:30 to about 95:5;said putty including insoluble collagen particles at a level of about 0.04 g/cc to about 0.15 g/cc, and soluble collagen particles, wherein the insoluble collagen particles to soluble collagen particles are at a weight ratio of 75:25 to about 65:35; andsaid putty including a polysaccharide component at a level of about 0.01 g/cc to about 0.2 g/cc, andsaid polysaccharide component comprising dextran and one or more ionic polysaccharide compounds, wherein the ionic polysaccharide compounds form anionically-cross-linked gel with one or more divalent or trivalent cations. 2. The implantable medical material of claim 1, wherein the weight ratio of the insoluble collagen particles to the polysaccharide component in the putty is in the range of about 4:1 to about 1:1. 3. The implantable medical material of claim 1, also comprising a biocompatible wetting agent, said wetting agent being an organic polyhydroxy compound. 4. The implantable medical material of claim 1, also comprising a biologically active agent. 5. The implantable medical material of claim 4, wherein said biologically active agent comprises recombinant human BMP-2. 6. The implantable medical material of claim 1, wherein said polysaccharide component comprises alginate and starch. 7. The implantable medical material of claim 1, wherein said polysaccharide component includes one or more members selected from the group consisting of alginate, starch, hyaluronic acid, chondroitin sulfate, dextran, dextran sulfate, heparin, heparin sulfate, heparin sulfate, chitosan, gellan gum, xanthan gum, guar gum, and K-carrageenan. 8. The implantable medical material of claim 1 further comprising a starch. 9. The implantable medical material of claim 8 further comprising an osteogenic protein. 10. The implantable medical material of claim 9, wherein the osteogenic protein comprises a bone morphogenic protein. 11. The implantable medical material of claim 10, wherein the one or more ionic polysaccharide compounds comprises an alginate. 12. The implantable medical material of claim 4, wherein the biologically active agent is selected from rhBMP-7 and rhGDF-5. 13. The implantable medical material of claim 1, wherein the cation comprises a divalent cation. 14. The implantable medical material of claim 13, wherein the divalent cation is calcium. 15. The implantable medical material of claim 13, wherein the divalent cation is strontium. 16. The implantable medical material of claim 1, wherein the cation comprises aluminum. 17. The implantable medical material of claim 1, wherein the polysaccharide compounds comprise gellan gum and carrageenans and said gellan gum and carrageenans are cross-linked. 18. The implantable medical material of claim 1, wherein the polysaccharide component further comprises alginate.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (56)
Lee Dosuk D. ; Rey Christian,FRX ; Aiolova Maria ; Tofighi Aliassghar, Bioresorbable ceramic composites.
Drohan William N. ; MacPhee Martin J. ; Miekka Shirley I. ; Singh Manish S. ; Elson Clive,CAX ; Taylor ; Jr. John R., Chitin hydrogels, methods of their production and use.
Neff Thomas ; Martin George ; Piez Karl A. ; Pihlajaniemi Taina,FIX ; Kivirikko Kari I.,FIX, Collagen-based methods and formulations for the treatment of arthritis.
Prewett Annamarie B. (Little Silver NJ) Stikeleather Roger C. (Doylestown PA), Demineralized bone particles and flowable osteogenic composition containing same.
Peterson Dale R. ; Nousek-Goebl Nancy, Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration.
Sheng Ping Zhong ; Arthur R. Madenjian ; Douglas E. Godshall ; John M. Ronan ; Samuel A. Thompson, Medical devices comprising hydrogel polymers having improved mechanical properties.
Wallace Donald G. (Menlo Park CA) Smestad Thomas L. (Palo Alto CA) McPherson John M. (Sunnyvale CA) Piez Karl A. (Menlo Park CA) Seyedin Saeid (Sunnyvale CA) Armstrong Rosa (Palo Alto CA), Methods of bone repair using collagen.
Prewett Annamarie B. (Little Silver NJ) Stikeleather Roger C. (Doylestown PA), Process for producing flowable osteogenic composition containing demineralized bone particles.
Prewett Annamarie B. (Little Silver NJ) Stikeleather Roger C. (Doylestown PA) Bogdansky Simon (Marlboro NJ) O\Leary Robert K. (Spring Lake NJ), Shaped, swollen demineralized bone and its use in bone repair.
Prewett Annamarie B. (Little Silver NJ) Stikeleather Roger C. (Doylestown PA) Bogdansky Simon (Marlboro NJ) O\Leary Robert K. (Spring Lake NJ), Shaped, swollen demineralized bone and its use in bone repair.
MacPhee Martin James ; Drohan William Nash ; Lasa ; Jr. Carlos I.,PHX ; Liau Gene ; Haudenschild Christian, Supplemented and unsupplemented tissue sealants, methods of their production and use.
Bogdansky Simon (Marlboro NJ) O\Leary Robert K. (Spring Lake NJ), Swollen demineralized bone particles, flowable osteogenic composition containing same and use of the composition in the.
Patat Jean-Louis,FRX ; Ouhayoun Jean-Pierre,FRX, Use of a porous calcium carbonate based material as support of a growth factor in the preparation of a bioabsorbable imp.
Vanderploeg, Eric; Seeherman, Howard; Wilson, Christopher G.; Wozney, John; Brown, Christopher T.; Kambouris, John A., Systems and methods for improved delivery of osteoinductive molecules in bone repair.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.